When to Block? Timing of Scalp Block in Craniotomy
Scalp Block Before Incision or Before Emergence in Craniotomy: A Randomized Controlled Evaluation of Effectiveness and Recovery Quality Via QoR-40
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to evaluate the effect of scalp block timing-whether administered preoperatively or postoperatively-on postoperative recovery quality in patients undergoing craniotomy. The recovery quality will be assessed using the validated Quality of Recovery-40 (QoR-40) questionnaire. A total of 60 patients, aged 18-80 years, classified as ASA I-III and with a Glasgow Coma Scale (GCS) score of 15 upon admission to the recovery unit, will be enrolled. The primary outcome is the QoR-40 score. Secondary outcomes include hemodynamic changes and pain intensity measured by the Visual Analog Scale (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJune 29, 2025
June 1, 2025
5 months
June 18, 2025
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Recovery Score
Patient recovery will be assessed using the validated Turkish version of the QoR-40 (Quality of Recovery-40) questionnaire, a 40-item Likert-type scale covering five domains: emotional state, physical comfort, psychological support, physical independence, and pain. The total score ranges from 40 (poor recovery) to 200 (excellent recovery).
The observation period extended from the beginning of surgery until 24 hours postoperatively.
Secondary Outcomes (4)
Perioperative Hemodynamic Changes
Intraoperative (Hemodynamic parameters were monitored from the beginning to the end of surgery.)
Perioperative Hemodynamic Changes
Intraoperative (Hemodynamic parameters were monitored from the beginning to the end of surgery.)
Intraoperative and Postoperative Opioid Consumption
Total opioid consumption will be recorded intraoperatively and within the first 24 hours postoperatively.
Postoperative Pain Scores
10 minutes, 2 hours, 6 hours, and 24 hours postoperatively
Other Outcomes (1)
Adverse effects
Postoperative 24 hours
Study Arms (2)
Early Scalp Block Group
ACTIVE COMPARATORPatients in this group will receive a scalp block with 0.25% bupivacaine (20 mL) administered under ultrasound guidance after the induction of general anesthesia but prior to head pinning
Postoperative Scalp Block Group
ACTIVE COMPARATORPatients in this group will receive a scalp block with 0.25% bupivacaine (20 mL) administered under ultrasound guidance at the end of surgery, before emergence from anesthesia.
Interventions
Following induction of general anesthesia and prior to head pinning (Mayfield clamp placement), a scalp block was performed under aseptic conditions using 20 mL of 0.25% bupivacaine. The block targeted six sensory nerves that innervate the scalp: Supraorbital nerve, Supratrochlear nerve, Auriculotemporal nerve ,Zygomaticotemporal nerve, Greater occipital nerve, Lesser occipital nerve. Each nerve was infiltrated subcutaneously at its anatomical location using a 25-gauge needle, with the total volume distributed evenly or proportionally across the injection sites.
In the pre-emergence group, the scalp block was performed at the end of surgery but before emergence from general anesthesia, while the patient was still under deep anesthesia. Under strict aseptic conditions, 20 mL of 0.25% bupivacaine was administered to block the following six sensory nerves innervating the scalp: Supraorbital nerve, Supratrochlear nerve, Auriculotemporal nerve, Zygomaticotemporal nerve, Greater occipital nerve, Lesser occipital nerve. The local anesthetic was injected subcutaneously at the anatomical landmarks of each nerve using a 25-gauge needle. The total volume was distributed evenly or proportionally depending on the area. No additional surgical stimulation occurred after the block, and extubation followed routine emergence from anesthesia.
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 80 years.
- Scheduled for craniotomy under general anesthesia.
- ASA physical status classification I to III.
- Glasgow Coma Scale (GCS) score of 15 at the time of emergence from anesthesia.
- Provide informed consent to participate in the study.
You may not qualify if:
- Chronic use of analgesic medications prior to surgery.
- Glasgow Coma Scale (GCS) score below 15 postoperatively.
- Allergy or hypersensitivity to local anesthetics or opioids used in the study.
- Contraindications for scalp block or patient-controlled analgesia.
- Patients with severe hepatic, renal, or cardiac dysfunction.
- Patients unable to comprehend or complete the QoR-40 questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sakarya University Training and Research Hospital
Sakarya, 54290, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- A blinded investigator will monitor intraoperative hemodynamics, evaluate opioid/analgesic use, and assess postoperative recovery using the QoR-40 questionnaire.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist, M.D.
Study Record Dates
First Submitted
June 18, 2025
First Posted
June 29, 2025
Study Start
June 1, 2025
Primary Completion
November 1, 2025
Study Completion
December 1, 2025
Last Updated
June 29, 2025
Record last verified: 2025-06